Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Is rituximab effective as a single agent in mantle-cell lymphoma?

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Grillo-López AJ (2004) The ODAC chronicles: Part II. Statistics and clinical medicine in the USA—the triumph of science over art? Expert Rev Anticancer Ther 4: 941–944

    Article  Google Scholar 

  2. Howard O et al. (2002) Rituxan/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma. J Clin Oncol 20: 1288–1294

    CAS  Article  Google Scholar 

  3. Demidem A et al. (1997) Chimeric antiCD20 (IDEC-C2B8) monoclonal antibody sensitizes a B-cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 12: 177–185

    CAS  Article  Google Scholar 

  4. Dreyling MH et al. (2003) Combined immuno-chemotherapy (R-FCM) results in superior remission and survival rates in recurrent follicular and mantle cell lymphoma—final results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG) [abstract]. Blood 102 (Suppl): a351

    Google Scholar 

  5. Lenz G et al. (2005) Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 23: 1984–1992

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Grillo-López, A. Is rituximab effective as a single agent in mantle-cell lymphoma?. Nat Rev Clin Oncol 2, 500–501 (2005). https://doi.org/10.1038/ncponc0297

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0297

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing